IP Library Granted Patent US 8,591,961
Granted Patent B2
US 8,591,961 · App. 13/294,116 · Granted Nov 26, 2013

Aesthetic treatment of scars and aging skin

Inventor: Alan David Widgerow (Irvine, CA)
Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,591,961
App. No.
13/294,116
Granted
Nov 26, 2013
Kind
B2
Abstract

Beneficial topical compositions for treating scar or aging skin are provided. In one embodiment, the compositions include Bulbine frutescens, Centella asiatica and a phenol derived from olives, such as oleuropein. The composition may be used in the treatment of scars formed during surgery. The composition may also be used cosmeceutically in the treatment of aged skin, and may include phosphatidylserine, vitamins, and other beneficial anti-aging ingredients.

Claims (18)

1. A topical composition for treating damaged skin in a human or animal in need thereof consisting essentially of effective amounts of a Bulbine frutescens extract, a Centella asiatica extract, an olive extract and a silicone.

2. The topical composition of claim 1 , wherein the olive extract contains oleuropein.

3. The topical composition of claim 1 , wherein the silicone contains dimethicone.

4. The topical composition of claim 1 , wherein the Bulbine frutescens extract is present in a range of about 0.25% to about 25% mass per mass of the topical composition.

5. The topical composition of claim 1 , wherein the Centella asiatica extract is present in a range of about 0.1% to about 10% mass per mass of the topical composition.

6. The topical composition of claim 1 , wherein the olive extract is present in a range of about 0.1% to about 5% mass per volume of the topical composition.

7. The topical composition of claim 1 , wherein the topical composition is in the form of a gel, cream or ointment.

8. The topical composition of claim 1 , wherein said topical composition contains at least one ingredient selected from the group consisting of water, a solvent, a preservative, a surfactant, a gelling agent, and a pH balancer.

9. The topical composition of claim 1 , wherein the topical composition contains at least one ingredient selected from the group consisting of phospholipids, amino acids, vitamins and peptides.

10. The topical composition of claim 1 , wherein the topical composition contains phosphatidylserine.

11. The topical composition of claim 1 , wherein the damaged skin has a wound or scarred skin.

12. The topical composition of claim 1 , wherein the damaged skin has one or more signs of aging in the skin.

13. The topical composition of claim 1 , wherein the damaged skin has age spots, stretch marks or wrinkles.

14. The topical composition of claim 1 , wherein the topical composition is an occlusive dressing.

15. A topical composition for treating damaged skin in a human or animal in need thereof consisting essentially of effective amounts of a Bulbine frutescens extract, a Centella asiatica extract, oleuropein, and dimethicone.

16. The topical composition of claim 15 , wherein the topical composition is in the form of a gel, cream or ointment.

17. A topical composition for treating damaged skin in a human or animal in need thereof consisting essentially of effective amounts of a Bulbine frutescens extract, a Centella asiatica extract, oleuropein, dimethicone and phosphatidylserine.

18. The topical composition of claim 17 , wherein the topical composition is in the form of a gel, cream or ointment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2023
From: WIDGEROW, ALAN DAVID
To: ALLERGAN, INC.
Reel/Frame 065132/0349 →
Continuity (3)
Continuation In Part 12554364 · Sep 4, 2009
Provisional Application 61094170 · Sep 4, 2008
Related Publication 20120058076A1 · Mar 8, 2012